ArticleJournal of thoracic disease2016

Factors that predict progression-free survival in Chinese lung adenocarcinoma patients treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Shaohua Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.